An orally active Cannabis extract with high content in cannabidiol attenuates chemical induced intestinal inflammation and hypermotility in the mouse
Anecdotal and scientific evidence suggests that Cannabis use may be beneficial in inflammatory bowel disease (IBD) patients. Here, we have investigated the effect of a standardized Cannabis sativa extract with high content of cannabidiol (CBD), here named CBD BDS for CBD botanical drug substance, on...
Saved in:
Main Authors: | Ester Pagano (Author), Raffaele Capasso (Author), Fabiana Piscitelli (Author), Barbara Romano (Author), Olga Alessandra Parisi (Author), Stefania Finizio (Author), Anna Lauritano (Author), Vincenzo Di Marzo (Author), Angelo A Izzo (Author), Francesca Borrelli (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis
by: Cristoforo Silvestri, et al.
Published: (2020) -
Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse
by: Fiorentina Roviezzo, et al.
Published: (2017) -
Effect of Evodiamine on Rat Colonic Hypermotility Induced by Water Avoidance Stress and the Underlying Mechanism
by: Ren H, et al.
Published: (2021) -
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
by: Zackary Montoya, et al.
Published: (2020) -
The Effects of Short-Chain Fatty Acids on Rat Colonic Hypermotility Induced by Water Avoidance Stress
by: Yuan F, et al.
Published: (2020)